Biodegradable microspheres using two different gelatin drug conjugates for the controlled delivery of methotrexate

International Journal of Pharmaceutics

Volumn 128, Issue 1-2, 1996, Pages 261-268

  Narayani, R ^a   Panduranga Rao, K ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

biodegradable microspheres; gelatin drug conjugate; methotrexate

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG CARRIER; GELATIN; METHOTREXATE; MICROSPHERE;

ARTICLE; DRUG CONJUGATION; DRUG RELEASE; PARTICLE SIZE; PRIORITY JOURNAL; SPECTROSCOPY;

EID: 0342723178     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04323-3     Document Type: Article

References (13)

1. Chu, B.C.F. and Howell, S.B., Pharmacological and therapeutic properties of carrier bound methotrexate against tumor confined to a third place body compartment. J. Pharmacol. Exp. Ther., 219, (1981), 389-393.
2. Ghosh, M.K., Dane, K.O. and Mitra, A.K., Preparation and characterisation of methotrexate-immunoglobulin conjugates. Drug. Design. Del., 4, (1988), 13-25.
3. Hiroshi, M., Len, S.W. and Yoichi, M., Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconj. Chem. 3, (1992), 351-362.
4. Jeong, S.Y. and Kim, S.W., Biodegradable polymeric drug delivery systems. Arch. Pharm., 9(2), (1986), 63-73.
5. Kim, C.K. and Oh, Y.K., Development of hydrophilic human serum albumin microspheres using a drug-conjugate. Int. J. Pharm., 47 (1988), 163-169.
6. Kotanagi, H., Fukuda, and Ogata, N., Potent effect of the monoclonal antibody-mitomycin C conjugate on human colon cancers. Jpn. J. Sug., 17, (1987), 47-50.
7. Li, X., Bennett, D.B., Adams, N.W. and Kim, S.W., A biodegradable injectable drug delivery system. In R.L. Dunn and R.M. Ottenbrite (Eds.), Polymeric Drug and Drug Delivery Systems. American Chemical Society, Washington, DC, 1990, pp. 101-116.
8. Mukhopadhyay, A. and Basu, S.K., Enhanced intracellular delivery of methotrexate by a receptor-mediated process. Biotech. Appl. Biochem., 12, (1990), 529-636.
9. Narayani, R. and Panduranga Rao, K., Preparation, characterisation and in vitro stability of hydrophilic gelatin microspheres using a gelatin-methotrexate conjugate. Int. J. Pharm., 95. (1993), 85-91.
10. Noguchi, A., Takahashi, T., Yamaguichi, T., Kitamura, K., Takakura, Y., Hasida, M. and Sezaki, H. (1992) Preparation and properties of the immunoconjugate composed of anti-human colon cancer monocolonal antibody and mitomycin C-dextran conjugate. Bioconj. Chem., 3. (1992), 132-137.
11. Shen, W.C. and Ryser, H.J.P., Poly-(L-lysine) and Poly (D-lysine) conjugates of methotrexate: different inhibitory effect on drug resistant cells. Mol. Pharmacol., 16 (1979), 614-622.
12. Shih, L.B. and Goldenberg, D.M., Effects of methotrexate-carcinoembryonic-antigen-antibody immunoconjugates on GW-39 human tumors in nude mice. Cancer Immunol. Immunother., 31, (1990), 197-201.
13. Takakura, Y., Kitajima, M., Matsumoto, S., Hashida, M. and Sezaki, H., Development of a novel polymeric prodrug of mitomicin C, mitomycin C-dextran conjugate with anionic charge. I. Physicochemical characteristics and in vivo antitumor activities. Int. J. Pharm., 37, (1987), 135-143.